Steven M. Pieper

Steven M. Pieper

Chief Financial OfficeratXeris Biopharma Holdings· In proxies 2023–2025

Pay in FY2025Xeris Biopharma Holdings stock +131.6% the same year

Steven M. Pieper was paid $1.9M in FY2025 (Dec). Xeris Biopharma Holdings stock rose 131.6% that year.

Pay$100 in the stock at the end of FY24 → $232
Pay is from the Summary Compensation Table of each Xeris Biopharma Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Xeris Biopharma HoldingsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +809%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?